| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Product revenue, net | $761.4M+12.8% | $675.0M+39.9% | $482.4M+20.0% | $401.9M+9.8% | $366.0M |
| Cost of sales | $13.0M+19.3% | $10.9M+67.9% | $6.5M+20.4% | $5.4M+2.0% | $5.3M |
| Research and development | $254.9M+3.2% | $246.9M+33.9% | $184.4M+40.7% | $131.0M+15.0% | $113.9M |
| Selling, general and administrative | $448.7M+60.1% | $280.3M+52.1% | $184.3M+20.6% | $152.8M+24.9% | $122.4M |
| Total operating expenses | $716.6M+33.2% | $538.1M+43.5% | $375.1M+29.7% | $289.2M+19.8% | $241.5M |
| Income from operations | $44.8M-67.3% | $137.0M+27.7% | $107.3M-4.8% | $112.6M-9.5% | $124.5M |
| Interest and other income | $21.7M-11.7% | $24.5M+42.1% | $17.3M+385.7% | $3.6M+572.4% | $529K |
| Income before income taxes | $66.5M-58.8% | $161.5M+29.7% | $124.6M+7.2% | $116.2M-7.1% | $125.0M |
| Income tax benefit (expense) | $33.2M+263.6% | -$20.3M-10.1% | -$18.4M-24.7% | -$14.8M-18.2% | -$12.5M |
| Net income | $99.7M-29.4% | $141.2M+33.0% | $106.1M+4.7% | $101.4M-9.9% | $112.5M |
| Net income attributable to common stockholders, basic | $98.2M-29.7% | $139.7M+32.5% | $105.5M+4.2% | $101.3M-10.0% | $112.5M |
| Net income attributable to common stockholders, diluted | $98.2M-29.7% | $139.7M+32.5% | $105.5M+4.2% | $101.3M-10.0% | $112.5M |
| Basic net income per share (in dollars per share) | $950.00-29.6% | $1350.00+32.4% | $1020.00+7.4% | $950.00-2.1% | $970.00 |
| Diluted net income per share (in dollars per share) | $820.00-33.3% | $1230.00+30.9% | $940.00+8.0% | $870.00-2.2% | $890.00 |
| Basic (in shares) | 103.9M+0.6% | 103.2M-0.3% | 103.6M-3.0% | 106.8M-7.7% | 115.7M |
| Diluted (in shares) | 120.0M+5.7% | 113.5M+1.6% | 111.7M-3.6% | 116.0M-7.9% | 126.0M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.